Allarity Therapeutics, Inc. Foreign Currency Transaction Loss, before Tax
Allarity Therapeutics, Inc. (ALLR) reported Foreign Currency Transaction Loss, before Tax of $100.00 thousand for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:ForeignCurrencyTransactionLossBeforeTax · last filed 2024-11-14
- Allarity Therapeutics, Inc. foreign currency transaction loss, before tax for the quarter ending 2024-09-30 was $100.00K.
- Allarity Therapeutics, Inc. foreign currency transaction loss, before tax for fiscal 2022 was $3.69M, a 33.69% decline from fiscal 2021.
- Allarity Therapeutics, Inc. foreign currency transaction loss, before tax for fiscal 2021 was $5.57M, a 294.33% increase from fiscal 2020.
- Allarity Therapeutics, Inc. foreign currency transaction loss, before tax for fiscal 2020 was $1.41M.
| Period end | Foreign Currency Transaction Loss, before Tax 3 month | Foreign Currency Transaction Loss, before Tax 12 month |
|---|---|---|
| 2024-09-30 | $100.00K 10-Q · filed 2024-11-14 | |
| 2022-12-31 | $3.69M 10-K · filed 2023-03-13 | |
| 2021-12-31 | $5.57M 10-K · filed 2023-03-13 | |
| 2020-12-31 | $1.41M 10-K · filed 2022-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |